Cargando…
Metabolism of ifosfamide during a 3 day infusion.
Urinary drug metabolites were measured in 21 patients receiving ifosfamide by continuous infusion over 3 days. Mean values for the proportion of drug excreted as parent compound, 2-dechloroethylifosfamide (2-DC), 3-dechloroethylifosfamide (3-DC), carboxyifosfamide (CX) and ifosforamide mustard (IPM)...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968912/ https://www.ncbi.nlm.nih.gov/pubmed/8180026 |
_version_ | 1782134843977498624 |
---|---|
author | Hartley, J. M. Hansen, L. Harland, S. J. Nicholson, P. W. Pasini, F. Souhami, R. L. |
author_facet | Hartley, J. M. Hansen, L. Harland, S. J. Nicholson, P. W. Pasini, F. Souhami, R. L. |
author_sort | Hartley, J. M. |
collection | PubMed |
description | Urinary drug metabolites were measured in 21 patients receiving ifosfamide by continuous infusion over 3 days. Mean values for the proportion of drug excreted as parent compound, 2-dechloroethylifosfamide (2-DC), 3-dechloroethylifosfamide (3-DC), carboxyifosfamide (CX) and ifosforamide mustard (IPM) were 19, 6, 10, 7 and 8% of dose respectively. The proportion of urinary drug products in the form of ifosfamide fell considerably over the course of the 3 days. This was mirrored by an increase in the proportion of 2-DC, 3-DC and CX. The proportion in the form of IPM, however, remained unchanged. With successive cycles the amount of 2-DC and IPM increased by about 10% per course. A very wide variation in the amount of each metabolite was reproducibly seen between patients, but no evidence for a genetic polymorphism was found. Urinary dechloroethyl metabolites correlated positively with each other and negatively with CX. Although autoinduction increases 'activation' of ifosfamide when given over 3 days, our evidence suggests that competing metabolic pathways prevent an increase in the amount of active metabolite formed. |
format | Text |
id | pubmed-1968912 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1994 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19689122009-09-10 Metabolism of ifosfamide during a 3 day infusion. Hartley, J. M. Hansen, L. Harland, S. J. Nicholson, P. W. Pasini, F. Souhami, R. L. Br J Cancer Research Article Urinary drug metabolites were measured in 21 patients receiving ifosfamide by continuous infusion over 3 days. Mean values for the proportion of drug excreted as parent compound, 2-dechloroethylifosfamide (2-DC), 3-dechloroethylifosfamide (3-DC), carboxyifosfamide (CX) and ifosforamide mustard (IPM) were 19, 6, 10, 7 and 8% of dose respectively. The proportion of urinary drug products in the form of ifosfamide fell considerably over the course of the 3 days. This was mirrored by an increase in the proportion of 2-DC, 3-DC and CX. The proportion in the form of IPM, however, remained unchanged. With successive cycles the amount of 2-DC and IPM increased by about 10% per course. A very wide variation in the amount of each metabolite was reproducibly seen between patients, but no evidence for a genetic polymorphism was found. Urinary dechloroethyl metabolites correlated positively with each other and negatively with CX. Although autoinduction increases 'activation' of ifosfamide when given over 3 days, our evidence suggests that competing metabolic pathways prevent an increase in the amount of active metabolite formed. Nature Publishing Group 1994-05 /pmc/articles/PMC1968912/ /pubmed/8180026 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Hartley, J. M. Hansen, L. Harland, S. J. Nicholson, P. W. Pasini, F. Souhami, R. L. Metabolism of ifosfamide during a 3 day infusion. |
title | Metabolism of ifosfamide during a 3 day infusion. |
title_full | Metabolism of ifosfamide during a 3 day infusion. |
title_fullStr | Metabolism of ifosfamide during a 3 day infusion. |
title_full_unstemmed | Metabolism of ifosfamide during a 3 day infusion. |
title_short | Metabolism of ifosfamide during a 3 day infusion. |
title_sort | metabolism of ifosfamide during a 3 day infusion. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968912/ https://www.ncbi.nlm.nih.gov/pubmed/8180026 |
work_keys_str_mv | AT hartleyjm metabolismofifosfamideduringa3dayinfusion AT hansenl metabolismofifosfamideduringa3dayinfusion AT harlandsj metabolismofifosfamideduringa3dayinfusion AT nicholsonpw metabolismofifosfamideduringa3dayinfusion AT pasinif metabolismofifosfamideduringa3dayinfusion AT souhamirl metabolismofifosfamideduringa3dayinfusion |